Skip to main content

Table 1 Association between NLR/PNI value and clinicopathological findings

From: Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer

 

Number

NLR

PNI

All cases

334

2.52 ± 2.06

51.03 ± 5.72

 Age

70

165

2.34 ± 1.91

52.20 ± 5.38*

 >70

169

2.69 ± 2.18

49.59 ± 5.70*

Smoking history

 Never

122

2.27 ± 1.69

52.32 ± 5.00**, ***

 Former

116

2.69 ± 2.41

49.70 ± 5.65**

 Current

95

2.64 ± 1.99

50.97 ± 6.36***

Histology

 Adenocarcinoma

231

2.43 + 2.07

51.87 + 5.17****

 Squamous cell carcinoma

69

2.80 + 2.30

48.22 + 6.49****

 Large cell carcinoma

22

2.84 + 1.42

49.55 + 6.38

 Adenosquamous carcinoma

6

2.01 + 0.61

52.49 + 2.39

 Pleomorphic carcinoma

6

1.90 + 0.93

55.07 + 6.92

Tumor differentiation

 Well

118

2.39 + 2.12

51.82 + 4.70

 Moderate

115

2.55 + 2.29

50.96 + 6.12

 Poor

101

2.59 + 1.70

50.23 + 6.30

Pathological stage

 IA

144

2.40 + 2.13

51.74 + 5.33

 IB

95

2.54 + 1.68

50.30 + 6.00

 IIA+IIB

55

2.60 + 2.21

50.30 + 5.50

 IIIA+IIIB

40

2.75 + 2.37

51.18 + 6.58

  1. NLR neutrophil/lymphocyte ratio, PNI prognostic nutritional index
  2. *, **, ****p < 0.01
  3. ***p < 0.05